Houston Nexium & Proton Pump Inhibitors (PPIs) Lawyer

Nexium and other PPIs have been associated with some serious side effects, including (but not necessarily limited to):

• Acute interstitial nephritis (AIN), serious inflammation of the kidneys – Marked by blood in the urine and bloating, AIN can lead to kidney failure.
• Clostridium difficile-associated diarrhea (CDAD), a severe form of diarrhea caused by an intestinal infection known as clostridium difficile – CDAD can cause severe dehydration, kidney problems, colon blockage and bowel perforation. Without treatment, the most serious CDAD cases can be deadly.
• Hypomagnesemia, dangerously low magnesium levels – This condition can impact nearly every biological system and potentially cause life-threatening complications, like arrhythmia and sudden death.
• Cyanocobalamin, severe Vitamin B12 deficiencies – These deficiencies can result in memory loss, mood changes, depression and nervous system complications. In the most serious cases, Vitamin B12 deficiencies can lead to dementia.
• Wrist, hip and spine fractures – The reduction of stomach acid caused by PPIs can result in reduced calcium absorption, increasing the risk of bone fractures.
• System lupus erythematosus (SLE) events – These events can trigger the autoimmune system to attack the body’s tissues, causing inflammation on the face or extremities (particularly following sun exposure). If left untreated, this condition can cause organ failure.
• Stroke – A 2016 study found that patients who were taking the highest available doses of Nexium and other PPIs had a 50 percent elevated risk of stroke.²

The FDA has taken various actions to warn the public about the many serious risks associated with taking Nexium and other PPIs. These include (but are not limited to):

• An October 2016 Warning regarding the risks of SLE events³
• Two December 2014 Safety Communications, with one pertaining the risks of AIN and the other related to the risks associated with cyanocobalamin⁴
• A February 2012 Warning, alerting the public about the risks of CDAD⁵
• A March 2011 Safety Communication regarding the risks of hypomagnesemia⁵
• A May 2010 Alert, warning about the risks of spine, hip and bone fractures.⁵

Hundreds of people have already taken action to file claims against AstraZeneca, Pfizer and other makers of PPI drugs, alleging that:

• These medications caused them to develop severe health complications.
• The drug makers were negligent in warning the public about the serious risks associated with Nexium and other PPIs.

As PPI claims have amassed in courts across the U.S., in August 2017, the Judicial Panel on Multidistrict Litigation (JPML) issued an order to transfer these actions to the U.S. District Court, District of New Jersey.⁶ The Proton Pump Inhibitor MDL (MDL No. 2789)⁷ is focused on facilitating discovery and pretrial proceedings for the many PPI claims that are currently pending.

Those who have a new Nexium or proton pump inhibitor claim may have the option to join the ongoing MDL or keep their case separate, depending on the details of their claim and other factors. An attorney at the Amaro Law Firm is ready to review your potential claim and explain your best options.

A dangerous drug lawyer at the Amaro Law Firm is ready to help you successfully navigate the path to recovery and justice if you or a loved one has been seriously harmed by Nexium or any PPI drug.

Call (713) 352-7975, text (281) 612-8024, or contact our firm for your FREE consultation and important answers regarding your potential claim.

With more than two decades of legal experience, our attorneys can provide you with exceptional advocacy as we help you obtain the financial recovery you deserve. While we are aware that no sum of money can ever reverse the permanent losses caused by PPIs, we also know that these recoveries can be the key to gaining justice and restoring lives.

The Amaro Law Firm’s record of effective representation and success in dangerous drug claims is affirmed by glowing testimonials from our former clients and our 5-star ratings on Google and Facebook.

________________________________________________________________________________

1: FDA Approval of Nexium
2: 2016 PPI & Stroke Study from the American Heart Association (AHA)
3: 2016 FDA Warning about PPIs & the SLE risk
4: 2014 FDA PPI Alerts about the risks of AIN & cyanocobalamin
5: FDA PPI Warnings Issued from May 2010 to Feb. 2012
6: JPML Transfer Order establishing the PPI MDL
7: PPI MDL Home Page